Why Biogen is purposefully becoming more risk averse, according to Biogen’s CEO

Biogen CEO Christopher Viehbacher has been working to course-correct after the company’s ruinous Aduhelm gamble — and shared at the STAT Summit how he plans to move the company forward in a pragmatic way. It’ll still be important to pursue risky projects, he emphasized, but in a more disciplined way.